FORMELA JEAN FRANCOIS sold $1.5M of KRRO (indirect holdings)
FORMELA JEAN FRANCOIS sold 110,023 indirectly-held shares of Korro Bio, Inc. (KRRO) at an average of $14.02 ($13.96–$14.03, $1.54M total) across 4 trades over 2026-07-02 to 2026-07-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the director’s open-market sale totaling ~$1.54M at ~$13.96–$14.03 per share, executed across four trades under a 10b5-1 plan.
Market read
Primarily a sentiment/positioning datapoint; no new guidance, trial, deal, or regulatory development is disclosed.
What to watch
Traders may still watch for follow-on insider activity (additional Form 4s) or whether other insiders/large holders are selling/buying around the same window.
Background
The article is an SEC Form 4 insider transaction disclosure for Korro Bio, Inc. (KRRO).
Ticker impact
Korro Bio director Formela Jean Francois sold $1.54M of KRRO via an open-market sale under a pre-arranged 10b5-1 plan (110,023 shares).
Likely limited near-term impact; any effect is more sentiment/flow-related than fundamental.
The filing is a routine Form 4 open-market sale with a stated 10b5-1 plan, and the article provides no new operational/regulatory/financial catalyst.
Market effects
No sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, the transaction may be mechanically scheduled and not a bearish signal.
Key entities
- issuerKorro Bio, Inc.
US-listed company whose director insider sale is disclosed on Form 4.
- insiderFormela Jean Francois
Director who sold 110,023 shares indirectly under a pre-arranged 10b5-1 plan.